Review clinical trials related to Juvenile Myopia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.
Is 7-14 years of age, inclusive [+6]
Is unable to complete the necessary study activities [+3]
The aim of this study is evaluate and compare the mobility performance of children in daily activities while wearing single vision spectacle lenses (control) versus myopia control spectacle lenses (test).
Are between the ages of 6 and 12 years of age (inclusive) at the time of informe... [+6]
Have any systemic disease that affects ocular health. [+5]
This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.
Previously a successfully completed participant in the CATHAY study (NCT05562622... [+3]
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
Children 6 - 8 years of age (inclusive) at time of informed consent/assent; [+8]
Subject has previously or currently wears contact lenses (greater than 1-month u... [+8]